Non–Q-Wave Versus Q-Wave Myocardial Infarction After Thrombolytic Therapy

Publisher Website
Google Scholar
Abstract
Background —Although the stratification of patients with myocardial infarction into ECG subsets based on the presence or absence of new Q waves has important clinical and prognostic utility, systematic evaluation of the impact of thrombolytic therapy on the subsequent development and prognosis of non–Q-wave infarction has been limited to date. Methods and Results —We examined 12-lead ECG, coronary anatomy, left ventricular function, and mortality among 2046 patients with ST-segment elevation infarction from the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries angiographic subset to gain further insight into the pathophysiology and prognosis of Q- versus non–Q-wave infarction in the thrombolytic era. Non–Q-wave infarction developed in 409 patients (20%) after thrombolytic therapy. Compared with Q-wave patients, non–Q-wave patients were more likely to present with lesser ST-segment elevation in a nonanterior location. The infarct-related artery in non–Q-wave patients was more likely to be nonanterior (67% versus 58%, P =.012) and distally located (33% versus 39%, P =.021). Early (90-minute, 77% versus 65%, P =.001) and complete (54% versus 44%, P <.001) infarct-related artery patency was greater among the non–Q-wave group. Non–Q-wave patients had better global (ejection fraction, 66% versus 57%; P <.0001) and regional left ventricular function (10 versus 24 abnormal chords, P =.0001). In-hospital, 30-day, 1-year, and 2-year (6.3% versus 10.1%, P =.02) mortality rates were lower among non–Q-wave patients. Conclusions —The excellent prognosis among the subgroup of patients who develop non–Q-wave infarction after thrombolysis is related to early, complete, and sustained infarct-related artery patency with resultant limitation of left ventricular infarction and dysfunction.

This publication has 22 references indexed in Scilit: